Population Pharmacokinetics of Apalutamide and its Active Metabolite N -Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects
ConclusionsA population pharmacokinetic modelling approach was successfully applied to describe the pharmacokinetics of apalutamide andN-desmethyl-apalutamide. No clinically relevant covariates were identified as predictors of apalutamide andN-desmethyl-apalutamide pharmacokinetics.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Oral Cancer | Prostate Cancer | Statistics | Study